Consumer Alert: J&J recalls Simponi injection pens used to treat rheumatoid-arthritis due to manufacturing problem. Pens may not deliver a full dose of medicine, which can lead to dangerous side effects for users. Patients advised to discard recalled products and consult their healthcare providers immediately.
Free Simponi Injection Pen Recall Case Evaluation: If you or a loved one has been injured by a product included in this recall, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the problem?
February 18, 2011 - In what seems to be yet another woe for troubled pharmaceutical giant Johnson & Johnson, the company announced this week that it is now recalling nearly 400 injection pens in the U.S. and Germany that are pre-loaded with Simponi, a rheumatoid-arthritis drug. The pens in question, which may not deliver a full dose of the medicine due to a manufacturing problem, were made at a plant in Switzerland. As an alternative, patients are being advised to use pre-filled syringes of Simponi.
The Simponi recall is just the latest in a series of product recalls at J&J due to manufacturing-quality lapses, which have hurt sales and damaged the company's once sterling reputation. The biggest impact has been on J&J's over-the-counter medicine brands including Children’s Tylenol, Motrin, & Benadryl. For a comprehensive list of the products currently being recalled by Johnson & Johnson, go to the McNeil Product Recall Information website. For more information about the Simponi arthritis injection pen, please visit the company website.
Do I have a Simponi Arthritis Pen Recall Lawsuit?
The Product Liability and Defective Medical Device Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Simponi arthritis pen recall lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.